Metraipolis › archive › dc_5f259f03349b
Empagliflozin Treatment for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:40959362
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40959362
- DOI
- 10.7759/cureus.90205
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T13:50:45.272Z
- SHA-256 of the archived text
2f875bc7a479de990fc18c33ffe26bd7d7c90c146d3cdc3b66a93b5ce9762096- Stable URL of this page
https://metraipolis.com/documento/dc_5f259f03349b
How to cite
Empagliflozin Treatment for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:40959362 — Europe PMC (en), https://europepmc.org/article/MED/40959362 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f259f03349b (Metraipolis archive dc_5f259f03349b, sha256 2f875bc7a479de990fc18c33ffe26bd7d7c90c146d3cdc3b66a93b5ce9762096)
BibTeX
@misc{dc5f259f03349b,
title = {Empagliflozin Treatment for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Europe PMC PMID:40959362},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40959362},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f259f03349b; sha256 2f875bc7a479de990fc18c33ffe26bd7d7c90c146d3cdc3b66a93b5ce9762096},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40959362. Agents can read the archived copy with the MCP tool read_document.